Northern Trust
INKT icon

Northern Trust’s MiNK Therapeutics INKT Stock Holding History

Northern Trust’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,144
Closed -$7.97K – 4466
2024
Q4 		$7.97K Buy
1,144
+37
+3% +$252 ﹤0.01% 4430
2024
Q3 		$8.3K Hold
1,107
– – ﹤0.01% 4389
2024
Q2 		$10.5K Sell
1,107
-3
-0.3% -$29 ﹤0.01% 4378
2024
Q1 		$10.1K Hold
1,110
– – ﹤0.01% 4389
2023
Q4 		$11.9K Sell
1,110
-3
-0.3% -$31 ﹤0.01% 4410
2023
Q3 		$12.2K Hold
1,113
– – ﹤0.01% 4384
2023
Q2 		$23.4K Buy
+1,113
New +$22.3K ﹤0.01% 4376

Other funds holding INKT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
C
Covestor London, United Kingdom $173M AUM 56.91% 1-Year Est. Return

Northern Trust's INKT Position: Q1 2025 in Review

Northern Trust sold out of MiNK Therapeutics (INKT) in Q1 2025, closing a stake of 1,144 shares — an estimated $7.97K sold.

Northern Trust first reported a position in INKT in Q2 2023 and held it in 7 quarters. The position peaked at $23.4K in Q2 2023. 17 funds tracked by Wall St. Rank hold INKT as of Q1 2025.

  • Northern Trust reported no remaining MiNK Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Northern Trust sold 1,144 MiNK Therapeutics shares in Q1 2025, an estimated $7.97K.
  • Northern Trust first reported a position in MiNK Therapeutics in Q2 2023 and held it in 7 quarters.
  • Northern Trust's MiNK Therapeutics position peaked at $23.4K in Q2 2023.
  • 17 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q1 2025.

Based on Northern Trust's 13F filing for Q1 2025, filed 13 May 2025.